Axiom Investors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,173,807
| Closed | -$33.4M | – | 151 |
|
|
2025
Q1 | $33.4M | Buy |
+2,173,807
| New | +$33.4M | 0.32% | 47 |
|
|
2016
Q3 | – | Sell |
-624,750
| Closed | -$31.4M | – | 160 |
|
|
2016
Q2 | $31.4M | Sell |
624,750
-551,009
| -47% | -$27.7M | 0.91% | 42 |
|
|
2016
Q1 | $62.9M | Sell |
1,175,759
-382,479
| -25% | -$20.5M | 1.96% | 16 |
|
|
2015
Q4 | $102M | Sell |
1,558,238
-376,969
| -19% | -$24.7M | 3.3% | 5 |
|
|
2015
Q3 | $109M | Buy |
1,935,207
+443,614
| +30% | +$25M | 3.45% | 6 |
|
|
2015
Q2 | $88.2M | Sell |
1,491,593
-55,345
| -4% | -$3.27M | 2.53% | 11 |
|
|
2015
Q1 | $96.4M | Buy |
1,546,938
+882,205
| +133% | +$55M | 2.61% | 8 |
|
|
2014
Q4 | $38.2M | Buy |
+664,733
| New | +$38.2M | 0.94% | 47 |
|